SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-024617
Filing Date
2020-12-30
Accepted
2020-12-30 17:27:19
Documents
52
Period of Report
2020-09-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 43730
2 ex99-1.htm EX-99.1 206960
3 ex99-2.htm EX-99.2 305361
4 ex99-3.htm EX-99.3 561287
5 ex99-1_001.jpg GRAPHIC 3481
  Complete submission text file 0001493152-20-024617.txt   3463765

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sigy-20200930.xml EX-101.INS 465455
7 XBRL SCHEMA FILE sigy-20200930.xsd EX-101.SCH 26667
8 XBRL CALCULATION FILE sigy-20200930_cal.xml EX-101.CAL 37912
9 XBRL DEFINITION FILE sigy-20200930_def.xml EX-101.DEF 119981
10 XBRL LABEL FILE sigy-20200930_lab.xml EX-101.LAB 174330
11 XBRL PRESENTATION FILE sigy-20200930_pre.xml EX-101.PRE 177205
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-55575 | Film No.: 201426835
SIC: 3841 Surgical & Medical Instruments & Apparatus